How many institutions own CKPT stock?

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own CKPT shares is 95, representing 42.18% of the company's common stock.

Who are the major shareholders selling Checkpoint Therapeutics, Inc. stock?

ENVESTNET ASSET MANAGEMENT INC, in the last quarter, reduced its stake in CKPT by -3.97% restricting it's holding to 64.19 thousand shares of worth nearly $259.31K. ROYAL BANK OF CANADA also lessened -33.09% of the CKPT shares from its portfolio, reducing its holding to 60.16 thousand shares of worth $243.00K. KESTRA ADVISORY SERVICES, LLC also shunned CKPT shares holding by -49.77% last quarter which brought its holding to 165.4 thousand shares worth $668.22K.

Investors who are buying CKPT stock?

As per its latest 13F filing, GLAZER CAPITAL, LLC increased its stake in CKPT by 100% in the last quarter. The institutional holder raised its holding to 3.17 million shares having worth more than $12.79M. BLACKROCK, INC. also added 1.09% more shares of CKPT to its portfolio, raising its holding to 288.37 thousand shares of worth $1.17M. VANGUARD GROUP INC also increased its CKPT shares holding by 5.82% which brought its holding to 2.01 million shares worth $8.11M.

CKPT's major insiders: who are they?

The insider with the most stakes in CKPT is Fortress Biotech, Inc. , 10 percent owner at the company. Additionally, CKPT stock is highly held by CEO, President and Director Oliviero James F III and Chief Financial Officer GRAY WILLIAM GARRETT among others.

Did an insider recently sell CKPT stock?

Company executives, directors, and other insiders own 14.05% percent of Checkpoint Therapeutics, Inc.'s stock. Within the last six months, there have been 0 transaction(s) in which CKPT insiders have sold stock, totaling 0 shares. Insiders that have sold shares include FORTRESS BIOTECH, INC., OLIVIERO JAMES F III, and GRAY WILLIAM GARRETT.

Which insider recently purchased CKPT stock?

There have been 0 transaction(s) during the past 6-months in which Checkpoint Therapeutics, Inc. insiders have bought stock, totalling 0 shares

How much of CKPT does insiders own?

Around 0 Checkpoint Therapeutics, Inc. shares are held by insiders, which represents about 14.05% of CKPT stock.

Who is the insider with the largest stake?

CKPT 10 percent owner, Fortress Biotech, Inc. holds the largest portfolio of the company's shares. CKPT shares owned by Fortress total nearly 6.12 million.

Which institution holds the most shares in CKPT?

ENVESTNET ASSET MANAGEMENT INC is the largest institutional owner in CKPT which holds 64.19 thousand shares worth $259.31K or 0.11% of the total CKPT shares outstanding followed by GLAZER CAPITAL, LLC with ownership of 3.17 million shares representing 5.29% of the CKPT ownership. BLACKROCK, INC. is the third largest stakeholder with 288.37 thousand shares or 0.48% of the ownership worth more than $1.17M.

Is Checkpoint Therapeutics, Inc. stock optionable?

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the CKPT is concerned, it is a stock which is optionable.

Is there a short position on CKPT's shares?

Number of CKPT shares short is 3.80M. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

About how many outstanding CKPT shares are there?

As of today, 86.32M shares of CKPT are outstanding.

Is there many float in CKPT stock?

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, CKPT has 59.15M shares in float.

CKPT short ratio: what is it?

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for CKPT is 2.19.

Checkpoint Therapeutics (CKPT) insider trading activity: Get Latest News Today

Stock Outstanding Shares

Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.

ShortableNo

OptionableYes

Short Percent Of Outstanding Shares4.36

Short Percent Of Float4.72

Shares Outstanding86.32M

Shares Float59.15M

Shares Short3.80M

Short Ratio2.19

4.72%

Short % of Float

4.36%

Short % of Shares Outstanding

Market Insider

Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.

Major Holders Summary

14.05% Percentage of Shares held by All Insiders

42.18% Percentage of Shares held by All Institutions

49.08% Percentage of Float held by Institutions

Number of Institutions Holding Shares

Institutional Ownership

About 42.18% of CKPT shares are held by financial institutions. ENVESTNET ASSET MANAGEMENT INC is the top corporate investor, holding 64.19K shares valued at $259.31K. A 0.11% stake in Checkpoint Therapeutics, Inc. is owned by the company. GLAZER CAPITAL, LLC owns 3.17M shares valued at $12.79M, which translates its holding of 5.29% of the stake in the company.

Date	Holder	% Stake	Shares Held	Total Value ($)	Shares	% Change in Portfolio
Mar 31, 2025	ENVESTNET ASSET MANAGEMENT INC	0.11%	64.19K	259.31K	-2.65K	-3.97%
Mar 31, 2025	GLAZER CAPITAL, LLC	5.29%	3.17M	12.79M	3.17M	+100.00%
Mar 31, 2025	BLACKROCK, INC.	0.48%	288.37K	1.17M	3.12K	+1.09%
Mar 31, 2025	VANGUARD GROUP INC	3.36%	2.01M	8.11M	110.48K	+5.82%
Mar 31, 2025	HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND	1.25%	750K	3.03M	750K	+100.00%
Mar 31, 2025	ROYAL BANK OF CANADA	0.1%	60.16K	243K	-29.76K	-33.09%
Mar 31, 2025	CARLSON CAPITAL L P	0.1%	60K	242.4K	60K	+100.00%
Mar 31, 2025	WEALTH ENHANCEMENT ADVISORY SERVICES, LLC	0.71%	426.1K	1.72M	1.1K	+0.26%
Mar 31, 2025		0.94%	560K	2.26M	560K	+100.00%
Mar 31, 2025	KESTRA ADVISORY SERVICES, LLC	0.28%	165.4K	668.22K	-163.88K	-49.77%
Mar 31, 2025	GROUPE LA FRANCAISE	1.4%	840K	3.39M	840K	+100.00%
Mar 31, 2025	ALPINE GLOBAL MANAGEMENT, LLC	0.42%	250K	1.01M	250K	+100.00%
Mar 31, 2025	NORTHERN TRUST CORP	0.39%	231.73K	936.18K	159.17K	+219.35%
Mar 31, 2025	VERITION FUND MANAGEMENT LLC	0.25%	150K	606K	150K	+100.00%
Mar 31, 2025	URSA FUND MANAGEMENT, LLC	0.17%	100K	404K	100K	+100.00%
Mar 31, 2025	TWO SIGMA INVESTMENTS, LP	0.12%	71.73K	289.78K	-1.31K	-1.79%
Mar 31, 2025	PARK AVENUE SECURITIES LLC	0.1%	59.92K	242K	0	0
Mar 31, 2025	SCHONFELD STRATEGIC ADVISORS LLC	0.87%	523.01K	2.11M	476.11K	+1,015.23%
Mar 31, 2025	CROWN ADVISORS MANAGEMENT, INC.	0.33%	200K	808K	200K	+100.00%
Mar 31, 2025	SUSQUEHANNA INTERNATIONAL GROUP, LLP	0.33%	195.2K	788.61K	111.6K	+133.49%
Mar 31, 2025	HB WEALTH MANAGEMENT, LLC	0.3%	180.56K	729.46K	27K	+17.58%
Mar 31, 2025	BLACK MAPLE CAPITAL MANAGEMENT LP	0.25%	150K	606K	150K	+100.00%
Mar 31, 2025	YAKIRA CAPITAL MANAGEMENT, INC.	0.2%	122.2K	493.69K	122.2K	+100.00%
Mar 31, 2025	TABOR ASSET MANAGEMENT, LP	0.2%	122.2K	493.69K	122.2K	+100.00%
Mar 31, 2025	CHOREO, LLC	0.16%	98.35K	397.33K	38.07K	+63.16%
Mar 31, 2025	HIGHBRIDGE CAPITAL MANAGEMENT LLC	6.41%	3.83M	15.48M	3.83M	+100.00%
Mar 31, 2025	TORONTO DOMINION BANK	5.72%	3.42M	13.84M	3.42M	+100.00%
Mar 31, 2025	BARCLAYS PLC	2.16%	1.29M	5.23M	1.29M	+100.00%
Mar 31, 2025	GABELLI FUNDS LLC	1.85%	1.11M	4.47M	1.11M	+100.00%
Mar 31, 2025	GABELLI & CO INVESTMENT ADVISERS, INC.	1.7%	1.02M	4.12M	1.02M	+100.00%
Mar 31, 2025	SAGEFIELD CAPITAL LP	0.28%	167.8K	677.91K	167.8K	+100.00%
Mar 31, 2025	BALYASNY ASSET MANAGEMENT L.P.	0.14%	81.54K	329.43K	61.32K	+303.25%
Mar 31, 2025	POLAR ASSET MANAGEMENT PARTNERS INC.	1.05%	629.86K	2.54M	629.86K	+100.00%
Mar 31, 2025	SQUAREPOINT OPS LLC	0.79%	471.39K	1.9M	399.45K	+555.27%
Mar 31, 2025	GEODE CAPITAL MANAGEMENT, LLC	0.78%	467.87K	1.89M	22.76K	+5.11%
Mar 31, 2025	MILLENNIUM MANAGEMENT LLC	0.67%	401.82K	1.62M	347.63K	+641.55%
Mar 31, 2025	JBF CAPITAL, INC.	0.28%	165K	666.6K	165K	+100.00%
Mar 31, 2025	PRELUDE CAPITAL MANAGEMENT, LLC	0.19%	113.08K	456.85K	113.08K	+100.00%
Mar 31, 2025	JANE STREET GROUP, LLC	0.16%	98.31K	397.17K	98.31K	+100.00%
Mar 31, 2025	PENDERFUND CAPITAL MANAGEMENT LTD.	0.16%	96.6K	351.81K	96.6K	+100.00%
Mar 31, 2025	CITADEL ADVISORS LLC	0.13%	75.5K	305.02K	-93.9K	-55.43%
Mar 31, 2025	XTX TOPCO LTD	0.12%	72.77K	293.98K	72.77K	+100.00%
Mar 31, 2025	CREDIT INDUSTRIEL ET COMMERCIAL	0.94%	560K	2.26M	560K	+100.00%
Mar 31, 2025	ADAR1 CAPITAL MANAGEMENT, LLC	0.51%	305.8K	1.24M	305.8K	+100.00%
Mar 31, 2025	OMERS ADMINISTRATION CORP	0.5%	300.8K	1.22M	183.9K	+157.31%
Mar 31, 2025	STATE STREET CORP	0.27%	158.85K	641.76K	10.3K	+6.93%
Mar 31, 2025	QUBE RESEARCH & TECHNOLOGIES LTD	0.12%	71.26K	287.89K	26.82K	+60.36%
Mar 31, 2025	CSS LLC/IL	0.11%	68.3K	275.93K	68.3K	+100.00%
Mar 31, 2025	UBS GROUP AG	0.11%	64.92K	262.28K	-6.85K	-9.54%
Mar 31, 2023	SPOTLIGHT ASSET GROUP, INC.	5.63%	661.6K	622K	661.6K	+100.00%

Insiders

Among the CKPT insiders holding of 14.05% of the stake in company, FORTRESS BIOTECH, INC., 10 percent owner, holds the largest shares of 6.12M. OLIVIERO JAMES F III, CEO, President and Director, is the second largest CKPT insider with ownership of 3.76M shares. GRAY WILLIAM GARRETT, Chief Financial Officer, stands third with possession of 1.45M shares of that stake.

Insiders	Designation	Shares Held
FORTRESS BIOTECH, INC.	10 percent owner	6.12M
OLIVIERO JAMES F III	CEO, President and Director	3.76M
GRAY WILLIAM GARRETT	Chief Financial Officer	1.45M
ROSENWALD LINDSAY A MD	director	237.89K

Buying/Selling by Insiders

Date	Insider	Type	Cost	Shares	Value ($)	Shares Total
May 29, 2025	FORTRESS BIOTECH, INC.	SALE	1.29	100K	129K	6.12M
Apr 02, 2025	OLIVIERO JAMES F III	SALE	4.04	15.09K	60.96K	3.76M
Apr 01, 2025	GRAY WILLIAM GARRETT	SALE	4.05	12.32K	49.9K	1.45M
Feb 10, 2025	OLIVIERO JAMES F III	SALE	3.15	10.33K	32.54K	3.78M
Feb 07, 2025	OLIVIERO JAMES F III	SALE	3.41	9.23K	31.48K	3.79M
Feb 06, 2025	GRAY WILLIAM GARRETT	SALE	3.67	74.11K	271.98K	1.46M
Dec 19, 2024	OLIVIERO JAMES F III	SALE	3.38	220.23K	744.38K	3.19M
Dec 18, 2024	OLIVIERO JAMES F III	SALE	3.87	602.17K	2.33M	3.41M
Dec 18, 2024	GRAY WILLIAM GARRETT	SALE	4.01	268.43K	1.08M	1.03M
Jun 26, 2024	OLIVIERO JAMES F III	SALE	2.05	24.61K	50.45K	1.98M
Jun 26, 2024	GRAY WILLIAM GARRETT	SALE	2.06	13.04K	26.86K	672.19K
Feb 28, 2024	GRAY WILLIAM GARRETT	SALE	2.07	2.04K	4.21K	145.22K
Feb 28, 2024	OLIVIERO JAMES F III	SALE	2.06	5.89K	12.14K	350.84K
Feb 01, 2024	OLIVIERO JAMES F III	SALE	2.01	11.9K	23.92K	369.68K
Feb 01, 2024	GRAY WILLIAM GARRETT	SALE	1.95	4.12K	8.02K	147.26K
Mar 02, 2023	GRAY WILLIAM GARRETT	SALE	5.00	3.59K	17.96K	51.37K
Mar 02, 2023	OLIVIERO JAMES F III	SALE	5.00	5.48K	27.42K	144.09K
Feb 27, 2023	GRAY WILLIAM GARRETT	SALE	4.66	1.91K	8.92K	47.47K
Feb 27, 2023	OLIVIERO JAMES F III	SALE	4.65	5.55K	25.8K	134.57K
Feb 01, 2023	GRAY WILLIAM GARRETT	SALE	4.79	3.15K	15.11K	49.38K
Feb 01, 2023	OLIVIERO JAMES F III	SALE	4.77	10.26K	48.94K	182.12K
Jan 10, 2023	GRAY WILLIAM GARRETT	SALE	6.75	1.86K	12.54K	52.53K
Jan 10, 2023	OLIVIERO JAMES F III	SALE	6.75	3.82K	25.76K	192.38K
Jun 22, 2022	OLIVIERO JAMES F III	SALE	1.09	12K	13.08K	2.58M
Jun 21, 2022	OLIVIERO JAMES F III	SALE	1.09	21K	22.89K	2.59M
Jun 17, 2022	OLIVIERO JAMES F III	SALE	1.11	15K	16.65K	2.56M
Apr 13, 2022	OLIVIERO JAMES F III	SALE	1.51	21.26K	32.1K	2.84M
Apr 05, 2022	OLIVIERO JAMES F III	SALE	1.77	14.03K	24.83K	2.86M
Apr 04, 2022	OLIVIERO JAMES F III	SALE	1.79	86.35K	154.57K	2.87M
Mar 10, 2022	GRAY WILLIAM GARRETT	SALE	1.89	38.2K	72.31K	543.91K
Feb 01, 2022	GRAY WILLIAM GARRETT	SALE	2.51	37.06K	92.95K	582.11K
Feb 05, 2021	OLIVIERO JAMES F III	SALE	3.42	48.79K	166.74K	3.15M
Feb 04, 2021	GRAY WILLIAM GARRETT	SALE	3.66	26.32K	96.32K	482.17K
Feb 04, 2021	OLIVIERO JAMES F III	SALE	3.51	70K	245.53K	3.2M
Dec 22, 2020	GRAY WILLIAM GARRETT	SALE	2.79	2.41K	6.71K	357.49K
May 21, 2020	GRAY WILLIAM GARRETT	SALE	2.00	17.1K	34.12K	359.9K
Nov 20, 2019	ROSENWALD LINDSAY A MD	PURCHASE	1.27	100K	127K	237.89K
Nov 09, 2018	ROSENWALD LINDSAY A MD	PURCHASE	2.35	49.67K	116.72K	126.45K
Nov 08, 2018	ROSENWALD LINDSAY A MD	PURCHASE	2.24	48.23K	108.04K	76.78K
Nov 07, 2018	ROSENWALD LINDSAY A MD	PURCHASE	2.12	2.1K	4.45K	28.55K

CKPT Stock Ownership Breakdown